Profil
Michael N.
Avallone has been Chief Financial Officer of AMAG Pharmaceuticals, Inc. since joining the company in July 2004 and Vice President of Finance since August 2004.
From 2000 to 2004, Mr. Avallone worked at Boston Biomedica, Inc., including as Corporate Controller and Vice President of Finance and Chief Financial Officer.
He held various executive positions in accounting and finance at affiliates of NSTAR.
Anciens postes connus de Michael N. Avallone
| Sociétés | Poste | Fin |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Directeur Financier/CFO | 21/03/2007 |
| PRESSURE BIOSCIENCES, INC. | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PRESSURE BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
